
|Videos|March 3, 2023
Considerations For ADT Selection And Patient Education on Treatment-Related AEs
Expert insight on selection of androgen deprivation therapy and how related adverse events may be communicated to patients in advance.
Advertisement
Episodes in this series

January 2023 AbbVie Inc. Company Confidential
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Kathryn Gessner, MD, PhD, on the challenges of selecting patients for bladder preservation
2
Study shows durable 3-year outcomes with first-line gemcitabine/docetaxel in NMIBC
3
First-in-human bladder transplant demonstrates sustained function at 6 months
4
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
5



















